Deals, Partnering

KINAXO Biotechnologies and Daiichi Sankyo Sign Collaboration Agreement

Posted on 28 September 2010

Tags: , ,

Long-term partnership in cancer research. Under the agreement, Daiichi Sankyo will employ KINAXO’s technology platform to support the development of Daiichi Sankyo’s targeted cancer drugs. This will involve KINAXO applying its proprietary chemical proteomics technologies Cellular Target Profiling® and KinAffinity® as well as its phosphoproteomics technology PhosphoScout® within various research programs pursued at Daiichi Sankyo. Financial details of the agreement were not disclosed

Read more at Kinaxo website (link no longer operational)

For further deal information visit Current Agreements (subscription required)

Print Friendly, PDF & Email

Leave a Reply